All Comments by

  1. Paul Coleman on A test of odor fluency in patients with Alzheimer's and Huntington's disease.
  2. Edward Koo on FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.
  3. John Olney on Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils.
  4. Hiroshi Mori on Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo.
  5. Hiroshi Mori on Discontinuous distribution of senile plaques within striate cortex hypercolumns in Alzheimer's disease.
  6. Edward Koo on Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.
  7. Edward Koo on Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.
  8. Hiroshi Mori on Stable association of presenilin derivatives and absence of presenilin interactions with APP.
  9. Hiroshi Mori on Suppression of A beta-induced monocyte neurotoxicity by antiinflammatory compounds.
  10. Paul Coleman on The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
  11. Hiroshi Mori on No man alone: the rediscovery of Alois Alzheimer's original cases.
  12. Benjamin Wolozin on alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells.
  13. Paul Coleman on cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease.
  14. Elliott Mufson on Educational level and neuropsychological heterogeneity in dementia of the Alzheimer type.
  15. Hiroshi Mori on Predicting the in vitro toxicity of synthetic beta-amyloid (1-40).